Results 131 to 140 of about 188 (145)

Efficacy of Biological-Targeted Treatments in Takayasu Arteritis

Circulation, 2015
Arsene Mekinian, Tristan Mirault, Jean-Emmanuel Kahn   +2 more
exaly  

Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)

Annals of the Rheumatic Diseases, 2018
Yoshikazu Nakaoka, Mitsuaki Isobe, Syuji Takei   +2 more
exaly  

Distribution of arterial lesions in Takayasu's arteritis and giant cell arteritis

Annals of the Rheumatic Diseases, 2012
Peter C Grayson, Gunnar Tomasson, David Cuthbertson   +2 more
exaly  

Th1 and Th17 Cytokines Drive Inflammation in Takayasu Arteritis

Arthritis and Rheumatology, 2015
Cloé Comarmond, Anne Claire Desbois, Michelle Rosenzwajg   +2 more
exaly  

ARTERITE DE TAKAYASU E COVID-19: ESTUDO DE CASO

2023
openaire   +1 more source

Takayasu arteritis is characterised by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab

Annals of the Rheumatic Diseases, 2012
Frank Buttgereit, Andreas Radbruch, Falk Hiepe   +2 more
exaly  

A Randomized, Double‐Blind Trial of Abatacept (CTLA‐4Ig) for the Treatment of Takayasu Arteritis

Arthritis and Rheumatology, 2017
David Cuthbertson, Nader Khalidi, Paul A Monach   +2 more
exaly  

Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan

Circulation, 2015
exaly  

Pathogenesis of Takayasu's arteritis: A 2011 update

Autoimmunity Reviews, 2011
Laurent Arnaud, Alexis Mathian, Guy Gorochov   +2 more
exaly  

Overview of Late Outcome of Medical and Surgical Treatment for Takayasu Arteritis

Circulation, 2008
exaly